Metastatic lung cancer with ALK/ROS1 fusion

Clinical trials for Metastatic lung cancer with ALK/ROS1 fusion explained in plain language.

Never miss a new study

Get alerted when new Metastatic lung cancer with ALK/ROS1 fusion trials appear

Sign up with your email to follow new studies for Metastatic lung cancer with ALK/ROS1 fusion, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New study investigates memory and mood problems in lung cancer patients on targeted therapy

Knowledge-focused Recruiting now

This study looks at memory, thinking, and mood problems that can happen with certain targeted lung cancer drugs (ALK/ROS1 inhibitors). About 20 patients who have these side effects will undergo detailed brain and psychiatric tests. The goal is to better understand these issues an…

Matched conditions: METASTATIC LUNG CANCER WITH ALK/ROS1 FUSION

Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:07 UTC

Metastatic lung cancer with ALK/ROS1 fusion

Get alerted when new Metastatic lung cancer with ALK/ROS1 fusion trials appear

New study investigates memory and mood problems in lung cancer patients on targeted therapy